- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 411/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 411/00
Total number of patents in this class: 60
10-year publication summary
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3735 |
3 |
| Bristol-myers Squibb Company | 4729 |
2 |
| Janssen Pharmaceutica N.V. | 3171 |
2 |
| Abbvie Inc. | 1836 |
2 |
| Hutchison MediPharma Enterprises Limited | 11 |
2 |
| Impact Biomedicines, Inc. | 33 |
2 |
| Spero Therapeutics, Inc. | 52 |
2 |
| Hoffmann-La Roche Inc. | 3783 |
1 |
| Genentech, Inc. | 4099 |
1 |
| Bayer Intellectual Property GmbH | 2379 |
1 |
| Amgen Inc. | 4425 |
1 |
| Merck Sharp & Dohme B.V. | 914 |
1 |
| FUJIFILM Corporation | 30512 |
1 |
| Sumitomo Chemical Company, Limited | 8996 |
1 |
| AbbVie Deutschland GmbH & Co. KG | 258 |
1 |
| Vertex Pharmaceuticals Incorporated | 1584 |
1 |
| Duke University | 3184 |
1 |
| Alexion Pharmaceuticals, Inc. | 648 |
1 |
| Arena Pharmaceuticals, Inc. | 344 |
1 |
| Astex Therapeutics Limited | 207 |
1 |
| Other owners | 32 |